Muscle tissue generally has a richer blood supply than subcutaneous fat, which could theoretically affect how quickly the medication enters the bloodstream
A provider-guided plan can help reduce this risk through nutrition support, strength activity, and monitoring
Dubbed the Ozempic Smell phenomenon, its raising questions about how these powerful appetite-suppressing medications may be subtly rewiring our senses
[1] [2] The pivotal SUSTAIN trials, which evaluated semaglutide for type 2 diabetes, and the STEP trials for weight management did not identify cold intolerance as a statistically significant adverse event
Please read the full announcement here
Its important to be patient and consistent with taking semaglutide as prescribed by your healthcare provider to allow your body enough time to adjust and experience the desired appetite-suppressing benefits